Skip to Content

Tivorbex Approval History

FDA Approved: Yes (First approved February 24, 2014)
Brand name: Tivorbex
Generic name: indomethacin
Dosage form: Capsules
Company: Iroko Pharmaceuticals, LLC
Treatment for: Pain

Tivorbex (indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain.

Development History and FDA Approval Process for Tivorbex

DateArticle
Feb 25, 2014Approval Iroko Pharmaceuticals Receives FDA Approval for Tivorbex

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide